MicroRNA-125b Induces Cancer Cell Apoptosis Through Suppression of Bcl-2 Expression

被引:89
作者
Zhao, Aihua [1 ,2 ,3 ]
Zeng, Quan [1 ]
Xie, Xiaoyan [1 ]
Zhou, Junnian [1 ]
Yue, Wen [1 ]
Li, Yali [2 ]
Pei, Xuetao [1 ]
机构
[1] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China
[2] PLA, Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China
[3] PLA, Hosp 309, Dept Obstet & Gynecol, Beijing 100091, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
miR-125b; Bcl-2; Apoptosis; Proliferation; HUMAN HEPATOCELLULAR-CARCINOMA; FAMILY PROTEINS; TUMORIGENICITY; OVEREXPRESSION;
D O I
10.1016/j.jgg.2011.12.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are small, noncoding RNAs which can often act as an oncogene or a tumor suppressor. Several miRNAs are associated with the development of hepatocellular carcinoma (HCC). We demonstrated that miR-125b significantly suppresses HCC cell proliferation and promotes apoptosis by inhibiting the gene expression of the anti-apoptotic protein, Bcl-2. Bioinformatic analysis indicated that the 3'UTR of Bcl-2 has binding sites for miR-125b. Luciferase reporter assay confirmed the ability of miR-125b to dramatically suppress Bcl-2 transcription, suggesting that Bcl-2 is a target gene for miR-125b. We concluded that miR-125b acts as a tumor suppressor in hepatic tumor development by targeting Bcl-2 and inducing cancer cell apoptosis.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 20 条
[1]   Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL [J].
Abou el Hassan, MAI ;
Mastenbroek, DCJ ;
Gerritsen, WR ;
Giaccone, G ;
Kruyt, FAE .
BRITISH JOURNAL OF CANCER, 2004, 91 (01) :171-177
[2]   Molecular Mechanisms of Hepatocellular Carcinoma [J].
Aravalli, Rajagopal N. ;
Steer, Clifford J. ;
Cressman, Erik N. K. .
HEPATOLOGY, 2008, 48 (06) :2047-2063
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers [J].
Calin, GA ;
Sevignani, C ;
Dan Dumitru, C ;
Hyslop, T ;
Noch, E ;
Yendamuri, S ;
Shimizu, M ;
Rattan, S ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2999-3004
[5]   miR-15 and miR-16 induce apoptosis by targeting BCL2 [J].
Cimmino, A ;
Calin, GA ;
Fabbri, M ;
Iorio, MV ;
Ferracin, M ;
Shimizu, M ;
Wojcik, SE ;
Aqeilan, RI ;
Zupo, S ;
Dono, M ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) :13944-13949
[6]   BCL-2 family proteins: Critical checkpoints of apoptotic cell death [J].
Danial, Nika N. .
CLINICAL CANCER RESEARCH, 2007, 13 (24) :7254-7263
[7]   A decade of caspases [J].
Degterev, A ;
Boyce, M ;
Yuan, JY .
ONCOGENE, 2003, 22 (53) :8543-8567
[8]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[9]   Identification of novel microRNA targets based on microRNA signatures in bladder cancer [J].
Ichimi, Takahiro ;
Enokida, Hideki ;
Okuno, Yasushi ;
Kunimoto, Ryo ;
Chiyomaru, Takeshi ;
Kawamoto, Ken ;
Kawahara, Kazuya ;
Toki, Kazuki ;
Kawakami, Kazumori ;
Nishiyama, Kenryu ;
Tsujimoto, Gozoh ;
Nakagawa, Masayuki ;
Seki, Naohiko .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) :345-352
[10]   MicroRNA gene expression deregulation in human breast cancer [J].
Iorio, MV ;
Ferracin, M ;
Liu, CG ;
Veronese, A ;
Spizzo, R ;
Sabbioni, S ;
Magri, E ;
Pedriali, M ;
Fabbri, M ;
Campiglio, M ;
Ménard, S ;
Palazzo, JP ;
Rosenberg, A ;
Musiani, P ;
Volinia, S ;
Nenci, I ;
Calin, GA ;
Querzoli, P ;
Negrini, M ;
Croce, CM .
CANCER RESEARCH, 2005, 65 (16) :7065-7070